The global glycomics market is driven by factors such as rise in number of biotechnology and biopharmaceutical companies, introduction of robust technology including glycan microarray and high-throughput mass spectroscopy and surge in demand for personalized medicine for treatment of various diseases. Moreover, government of various countries are rising financial support from the World Bank, and from the private and public organization to invest in life science field for glycomics and proteomics research, and hence it is expected to boost the growth of the global glycomics market during the forecast period. However, lack of awareness about the importance of glycomics among specialist is the major factor hampering the growth of the global glycomics market.
Market players included in research study of the global glycomics market are Takara Bio, Inc., Agilent Technologies, Merck KGaA, Bruker, Fisher Scientific, Inc., Thermo, New England Biolabs, Danaher, ProZym and Shimadzu Corporation.
Takara Bio Inc.
Founded in 2002 and headquartered at Kusatsu, Shiga, Japan. It is a biopharmaceutical company. This company develops and researches reagents for genome analysis and engineering, technology which is used for gene therapy, and natural health food products using mushrooms and seaweed body and extract. It was the first company to offer PCR technology in Japan and it is also the developer of the RetroNectin reagent. Its parent organization is Takara Holdings.
With its strong network of subsidiaries, this company has its presence in various countries. The major subsidiaries of this company are Takara Bio Europe AB, Takara Bio Europe S.A., Takara Bio USA Holdings, Inc., Cellectis AB, Takara Biomedical Technology [Beijing], Takara Biotechnology (Dalian) Co., Ltd., Pulmuone Takara Agri Co., Ltd., Takara Bio USA, Inc., Dss Takara Bio Pvt. Ltd., Takara Bio USA Inc., and Takara Bio Farming Center Inc.
Agilent Technologies Inc.
Founded in 1999 and headquartered at Santa Clara, California, United States. It is an American public incorporation engaged in research, development and manufacturing of analytical instruments, software, services and consumables for the entire laboratory workflow. The company focuses its products and services on six markets including food, forensics, environmental, diagnostics, pharmaceutical, chemical and energy, and research.
Major division of this company are Agilent CrossLab Group, Diagnostics & Genomics Group, Life Sciences & Applied Markets Group. With its strong network and subsidiaries, this company has its presence in various regions. The major subsidiaries of Agilent Inc. are Varian, Inc., BioTek, ACEA Biosciences, Inc, ProZyme, Inc., Agilent Technologies Deutschland GmbH, Agilent Technologies Singapore Pte. Ltd., and Advanced Analytical Technologies, Inc.
Fisher Scientific International Inc.
Founded in 1902 and headquartered at Hampton, New Hampshire, United States. It is a manufacturer of specialty chemicals. The Company produces a wide range of chemical products such as basic solutions, bio reagents and biochemical. In 2006, Fisher Scientific merged with Thermo Electron. Its parent organization are Thermo Fisher Scientific, Fisher Scientific Worldwide Inc., and Fisher Canada Partnership.
With its strong network and subsidiaries, this company operates worldwide. The major subsidiaries of this company are Fisher Scientific Co LLC, Fisher Hamilton LLC, Fisher Scientific Worldwide Inc, Duke Scientific Corporation, Cole-Parmer Canada Company, Diagnostix Ltd, CTPS Co, Fisher Germany Holdings GmbH, Microgenics SAS, Fisher Scientific Latin America Inc, Fisher Scientific Operating Company, Golden West Indemnity Company, and FRC Holding Inc V.
For More Information: https://www.reportocean.com/industry-verticals/details?report_id=PMI342